Recent evidence shows that through best standard operating procedures, chances of successful pregnancy and live birth delivery rates are less than 50%. Repeated Implantation Failure (RIF) following transfer of one or more numbers of cleavage or blastocyst stage embryos is the main cause of low pregnancy rate in IVF cycles; therefore, finding the causes and modifying treatment protocols to increase IVF success rates are currently hot topics for research. RIF is defined as a failed pregnancy following transfer of ten or more high quality embryos through at least three cycles of fresh embryo transfer (1). A successful pregnancy following embryo transfer depends on the three sides of implantation triangle: a receptive endometrium, a good quality embryo at the blastocyst stage and synchronization between endometrium and embryo through appropriate molecular dialogues. Uterine and ovarian disorders such as endometriosis, endometrial polyps, adhesions, uterine septa, submucosal and intramural fibroids, endometritis, adenomyosis, hydrosalpinx, leiomyoma and polycystic ovarian syndrome (PCOS) are associated with repeated implantation failure. Different studies have shown that resection of submucosal fibroids and intrauterine septum, hysterescopic polypectomy, salpingectomy, endometriosis surgery and myomectomy improve implantation and clinical pregnancy rates through molecular changes in endometrial steroid receptors, and changes in gene expression such as integrins, LIF, EMX2, HOXA-10 and IGFBP-1. (2).Therefore, gynecological surgery to provide a receptive endometrium is suggested as the first line of intervention in RIF due to the aforesaid uterine anomalies. Regarding the physiological role of endometrium in reproduction, due attention needs to be given to discovery of novel biomarkers for establishing the implantation window and monitoring endometrial thickness and receptivity. The aforesaid measures will change the outcome of ART cycles, especially RIF cycles.
